Tag: Brazilian Association of Vaccination Clinics
RIO DE JANEIRO, BRAZIL - The immunizer is in Phase 3 trials in India and is dependent on ANVISA approval to be administered in Brazil. The agency finds no obstacle in the private network application.
The most optimistic scenario estimates...